Page last updated: 2024-08-24

coomassie brilliant blue and nigericin

coomassie brilliant blue has been researched along with nigericin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Liu, X; Liu, Y; Lv, R; Wang, Y; Wen, Q; Wu, P; Wu, X; Zhou, G	1

Other Studies

1 other study(ies) available for coomassie brilliant blue and nigericin

Article	Year
P2X7 Receptor-Induced Bone Cancer Pain by Regulating Microglial Activity via NLRP3/IL-1beta Signaling. Pain physician, 2022, Volume: 25, Issue:8 Topics: Animals; Cancer Pain; Female; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Microglia; Neoplasms; NF-kappa B; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Receptors, Purinergic P2X7; RNA, Small Interfering; Signal Transduction	2022

Article

Year

P2X7 Receptor-Induced Bone Cancer Pain by Regulating Microglial Activity via NLRP3/IL-1beta Signaling.

Pain physician, 2022, Volume: 25, Issue:8

Topics: Animals; Cancer Pain; Female; Inflammasomes; Interleukin-1beta; Lipopolysaccharides; Microglia; Neoplasms; NF-kappa B; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Receptors, Purinergic P2X7; RNA, Small Interfering; Signal Transduction

2022